Sullivan Lara 4
4 · Pyxis Oncology, Inc. · Filed Sep 18, 2023
Insider Transaction Report
Form 4
Sullivan Lara
DirectorPresident ,CEO & CMO
Transactions
- Sale
Common Stock
2023-09-14$2.25/sh−100$225→ 2,412,423 total - Sale
Common Stock
2023-09-18$2.10/sh−8,541$17,936→ 2,403,882 total